Lanx Completes $15m Series C
Lanx has closed a $15 million Series C equity financing. Lanx is a global spine company focused on developing and commercializing innovative devices for fusion surgery. The financing round was led by new investor Credit Suisse Asset Management.
14 May 2013•2 mins read
